SerbinCommunications

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbin.com LA / NY / UK

Vedolizumab® 

Prev Next
Previous

Male with Organs and Inflammatory Bowel

medical illustration of Monoclonal antibody drug Vedolizumab®. An anti-integrin therapy with a selective mechanism of action, for use in primary types of inflammatory bowel disease - ulcerative colitis and Crohn's disease.
Next medical illustration of Booth graphic and advertising image for Livalo® (high cholesterol drug); highlighting metabolic pathway of Livalo versus other medications

Livalo®: Main Metabolic Pathway

Monoclonal antibody drug Vedolizumab®. An anti-integrin therapy with a selective mechanism of action, for use in primary types of inflammatory bowel disease - ulcerative colitis and Crohn's disease.

Keywords: Airbrush, Color, Line with Color, Advertising / Marketing, Editorial, Education, Web, Cell biology / Histology, Disease Management, Molecular Biology, Pharmacology, Virology

© Mica Duran